Optimized sequential therapy < em > vs < /em > 10- and 14-d concomitant therapy for eradicating < em > Helicobacter pylori < /em > : A randomized clinical trial
CONCLUSION: The optimized 14-d sequential therapy is a safe and effective alternative. Its eradication rate is comparable to that of the 14-d concomitant therapy while causing fewer AEs and allowing a gain in terms of cost.PMID:38463026 | PMC:PMC10921140 | DOI:10.3748/wjg.v30.i6.556 (Source: World Journal of Gastroenterology : WJG)
Source: World Journal of Gastroenterology : WJG - March 11, 2024 Category: Gastroenterology Authors: Hassan Seddik Jihane Benass Sanaa Berrag Asmae Sair Reda Berraida Hanae Boutallaka Source Type: research
Optimized sequential therapy < em > vs < /em > 10- and 14-d concomitant therapy for eradicating < em > Helicobacter pylori < /em > : A randomized clinical trial
CONCLUSION: The optimized 14-d sequential therapy is a safe and effective alternative. Its eradication rate is comparable to that of the 14-d concomitant therapy while causing fewer AEs and allowing a gain in terms of cost.PMID:38463026 | PMC:PMC10921140 | DOI:10.3748/wjg.v30.i6.556 (Source: World Journal of Gastroenterology : WJG)
Source: World Journal of Gastroenterology : WJG - March 11, 2024 Category: Gastroenterology Authors: Hassan Seddik Jihane Benass Sanaa Berrag Asmae Sair Reda Berraida Hanae Boutallaka Source Type: research
Optimized sequential therapy < em > vs < /em > 10- and 14-d concomitant therapy for eradicating < em > Helicobacter pylori < /em > : A randomized clinical trial
CONCLUSION: The optimized 14-d sequential therapy is a safe and effective alternative. Its eradication rate is comparable to that of the 14-d concomitant therapy while causing fewer AEs and allowing a gain in terms of cost.PMID:38463026 | PMC:PMC10921140 | DOI:10.3748/wjg.v30.i6.556 (Source: World Journal of Gastroenterology)
Source: World Journal of Gastroenterology - March 11, 2024 Category: Gastroenterology Authors: Hassan Seddik Jihane Benass Sanaa Berrag Asmae Sair Reda Berraida Hanae Boutallaka Source Type: research
Optimized sequential therapy < em > vs < /em > 10- and 14-d concomitant therapy for eradicating < em > Helicobacter pylori < /em > : A randomized clinical trial
CONCLUSION: The optimized 14-d sequential therapy is a safe and effective alternative. Its eradication rate is comparable to that of the 14-d concomitant therapy while causing fewer AEs and allowing a gain in terms of cost.PMID:38463026 | PMC:PMC10921140 | DOI:10.3748/wjg.v30.i6.556 (Source: World Journal of Gastroenterology)
Source: World Journal of Gastroenterology - March 11, 2024 Category: Gastroenterology Authors: Hassan Seddik Jihane Benass Sanaa Berrag Asmae Sair Reda Berraida Hanae Boutallaka Source Type: research
Optimized sequential therapy < em > vs < /em > 10- and 14-d concomitant therapy for eradicating < em > Helicobacter pylori < /em > : A randomized clinical trial
CONCLUSION: The optimized 14-d sequential therapy is a safe and effective alternative. Its eradication rate is comparable to that of the 14-d concomitant therapy while causing fewer AEs and allowing a gain in terms of cost.PMID:38463026 | PMC:PMC10921140 | DOI:10.3748/wjg.v30.i6.556 (Source: World Journal of Gastroenterology : WJG)
Source: World Journal of Gastroenterology : WJG - March 11, 2024 Category: Gastroenterology Authors: Hassan Seddik Jihane Benass Sanaa Berrag Asmae Sair Reda Berraida Hanae Boutallaka Source Type: research
Optimized sequential therapy < em > vs < /em > 10- and 14-d concomitant therapy for eradicating < em > Helicobacter pylori < /em > : A randomized clinical trial
CONCLUSION: The optimized 14-d sequential therapy is a safe and effective alternative. Its eradication rate is comparable to that of the 14-d concomitant therapy while causing fewer AEs and allowing a gain in terms of cost.PMID:38463026 | PMC:PMC10921140 | DOI:10.3748/wjg.v30.i6.556 (Source: World Journal of Gastroenterology : WJG)
Source: World Journal of Gastroenterology : WJG - March 11, 2024 Category: Gastroenterology Authors: Hassan Seddik Jihane Benass Sanaa Berrag Asmae Sair Reda Berraida Hanae Boutallaka Source Type: research
Optimized sequential therapy < em > vs < /em > 10- and 14-d concomitant therapy for eradicating < em > Helicobacter pylori < /em > : A randomized clinical trial
CONCLUSION: The optimized 14-d sequential therapy is a safe and effective alternative. Its eradication rate is comparable to that of the 14-d concomitant therapy while causing fewer AEs and allowing a gain in terms of cost.PMID:38463026 | PMC:PMC10921140 | DOI:10.3748/wjg.v30.i6.556 (Source: World Journal of Gastroenterology)
Source: World Journal of Gastroenterology - March 11, 2024 Category: Gastroenterology Authors: Hassan Seddik Jihane Benass Sanaa Berrag Asmae Sair Reda Berraida Hanae Boutallaka Source Type: research
Optimized sequential therapy < em > vs < /em > 10- and 14-d concomitant therapy for eradicating < em > Helicobacter pylori < /em > : A randomized clinical trial
CONCLUSION: The optimized 14-d sequential therapy is a safe and effective alternative. Its eradication rate is comparable to that of the 14-d concomitant therapy while causing fewer AEs and allowing a gain in terms of cost.PMID:38463026 | PMC:PMC10921140 | DOI:10.3748/wjg.v30.i6.556 (Source: World Journal of Gastroenterology : WJG)
Source: World Journal of Gastroenterology : WJG - March 11, 2024 Category: Gastroenterology Authors: Hassan Seddik Jihane Benass Sanaa Berrag Asmae Sair Reda Berraida Hanae Boutallaka Source Type: research
Optimized sequential therapy < em > vs < /em > 10- and 14-d concomitant therapy for eradicating < em > Helicobacter pylori < /em > : A randomized clinical trial
CONCLUSION: The optimized 14-d sequential therapy is a safe and effective alternative. Its eradication rate is comparable to that of the 14-d concomitant therapy while causing fewer AEs and allowing a gain in terms of cost.PMID:38463026 | PMC:PMC10921140 | DOI:10.3748/wjg.v30.i6.556 (Source: World Journal of Gastroenterology)
Source: World Journal of Gastroenterology - March 11, 2024 Category: Gastroenterology Authors: Hassan Seddik Jihane Benass Sanaa Berrag Asmae Sair Reda Berraida Hanae Boutallaka Source Type: research
Optimized sequential therapy < em > vs < /em > 10- and 14-d concomitant therapy for eradicating < em > Helicobacter pylori < /em > : A randomized clinical trial
CONCLUSION: The optimized 14-d sequential therapy is a safe and effective alternative. Its eradication rate is comparable to that of the 14-d concomitant therapy while causing fewer AEs and allowing a gain in terms of cost.PMID:38463026 | PMC:PMC10921140 | DOI:10.3748/wjg.v30.i6.556 (Source: World Journal of Gastroenterology : WJG)
Source: World Journal of Gastroenterology : WJG - March 11, 2024 Category: Gastroenterology Authors: Hassan Seddik Jihane Benass Sanaa Berrag Asmae Sair Reda Berraida Hanae Boutallaka Source Type: research
Optimized sequential therapy < em > vs < /em > 10- and 14-d concomitant therapy for eradicating < em > Helicobacter pylori < /em > : A randomized clinical trial
CONCLUSION: The optimized 14-d sequential therapy is a safe and effective alternative. Its eradication rate is comparable to that of the 14-d concomitant therapy while causing fewer AEs and allowing a gain in terms of cost.PMID:38463026 | PMC:PMC10921140 | DOI:10.3748/wjg.v30.i6.556 (Source: World Journal of Gastroenterology)
Source: World Journal of Gastroenterology - March 11, 2024 Category: Gastroenterology Authors: Hassan Seddik Jihane Benass Sanaa Berrag Asmae Sair Reda Berraida Hanae Boutallaka Source Type: research
Optimized sequential therapy < em > vs < /em > 10- and 14-d concomitant therapy for eradicating < em > Helicobacter pylori < /em > : A randomized clinical trial
CONCLUSION: The optimized 14-d sequential therapy is a safe and effective alternative. Its eradication rate is comparable to that of the 14-d concomitant therapy while causing fewer AEs and allowing a gain in terms of cost.PMID:38463026 | PMC:PMC10921140 | DOI:10.3748/wjg.v30.i6.556 (Source: World Journal of Gastroenterology : WJG)
Source: World Journal of Gastroenterology : WJG - March 11, 2024 Category: Gastroenterology Authors: Hassan Seddik Jihane Benass Sanaa Berrag Asmae Sair Reda Berraida Hanae Boutallaka Source Type: research
Optimized sequential therapy < em > vs < /em > 10- and 14-d concomitant therapy for eradicating < em > Helicobacter pylori < /em > : A randomized clinical trial
CONCLUSION: The optimized 14-d sequential therapy is a safe and effective alternative. Its eradication rate is comparable to that of the 14-d concomitant therapy while causing fewer AEs and allowing a gain in terms of cost.PMID:38463026 | PMC:PMC10921140 | DOI:10.3748/wjg.v30.i6.556 (Source: World Journal of Gastroenterology)
Source: World Journal of Gastroenterology - March 11, 2024 Category: Gastroenterology Authors: Hassan Seddik Jihane Benass Sanaa Berrag Asmae Sair Reda Berraida Hanae Boutallaka Source Type: research
Optimized sequential therapy < em > vs < /em > 10- and 14-d concomitant therapy for eradicating < em > Helicobacter pylori < /em > : A randomized clinical trial
CONCLUSION: The optimized 14-d sequential therapy is a safe and effective alternative. Its eradication rate is comparable to that of the 14-d concomitant therapy while causing fewer AEs and allowing a gain in terms of cost.PMID:38463026 | PMC:PMC10921140 | DOI:10.3748/wjg.v30.i6.556 (Source: World Journal of Gastroenterology : WJG)
Source: World Journal of Gastroenterology : WJG - March 11, 2024 Category: Gastroenterology Authors: Hassan Seddik Jihane Benass Sanaa Berrag Asmae Sair Reda Berraida Hanae Boutallaka Source Type: research
Optimized sequential therapy < em > vs < /em > 10- and 14-d concomitant therapy for eradicating < em > Helicobacter pylori < /em > : A randomized clinical trial
CONCLUSION: The optimized 14-d sequential therapy is a safe and effective alternative. Its eradication rate is comparable to that of the 14-d concomitant therapy while causing fewer AEs and allowing a gain in terms of cost.PMID:38463026 | PMC:PMC10921140 | DOI:10.3748/wjg.v30.i6.556 (Source: World Journal of Gastroenterology)
Source: World Journal of Gastroenterology - March 11, 2024 Category: Gastroenterology Authors: Hassan Seddik Jihane Benass Sanaa Berrag Asmae Sair Reda Berraida Hanae Boutallaka Source Type: research
